The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-Philippines seals biggest COVID-19 vaccine order yet, for 40 mln Pfizer doses

Sun, 20th Jun 2021 16:45

* Deliveries to begin in late September

* Philippines has secured 113 mln doses from vaccine
suppliers

* Government wants to vaccinate up to 70 million Filipinos
(Updates with Israel medical experts arriving to help boost
vaccine rollout)

MANILA, June 20 (Reuters) - The Philippine government has
signed a supply agreement for 40 million doses of the COVID-19
vaccine developed by Pfizer Inc and BioNTech SE,
in its biggest coronavirus vaccine deal to date.

Deliveries of the vaccine will begin in late September,
Carlito Galvez, head of the government's COVID-19 vaccine
procurement, said on Sunday. It "will significantly boost our
national immunisation programme and will enable us to realise
our goal of achieving herd immunity by year-end," he said.

The Philippines has now ordered 113 million doses from five
vaccine manufacturers, including 26 million from China's Sinovac
, 10 million of Russia's Sputnik V, 20 million doses from
Moderna and 17 million doses from AstraZeneca.

So far, the Philippines has adminstered slightly more than 8
million doses, of which about 6 million were first doses, making
slow progress towards the government's target to vaccinate up to
70 million people this year in a country of 110 million.

The Philippines earlier this month started a programme to
vaccinate 35 million people working outside their homes, while
continuing to inoculate priority sectors such as healthcare
workers and the elderly.

Vaccine supply around the capital Manila remains limited,
while COVID-19 cases in several provinces have surged,
complicating efforts to ramp up the immunisation drive in a
country with some of Asia's largest numbers of infections and
deaths.

The Philippines also expects 44 million doses from the
international COVAX vaccine sharing facility. Orders of 16
million doses of vaccines developed by Novavax and
Johnson & Johnson were still under negotiation, Galvez
said.

The Philippines will allow the Pfizer-BioNTech vaccine to be
given to children aged 12 to 15, possibly starting later this
year, he said.

To help boost the government's COVID-19 response, a team of
medical experts from the Israel Ministry of Health has arrived
in Manila. Israel has been a world leader in rolling out
vaccines, having successfully reduced its active COVID-19 cases
and gradually reopened its economy. Most of its population has
received the Pfizer-BioNTech vaccine.

Galvez said the health experts will share strategies,
including how to address vaccine hesitancy.
(Reporting by Enrico Dela Cruz; Editing by William Mallard and
Christopher Cushing)

More News
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.